Mutations in presenilin 1 (PSEN1) are the most common cause of autosomal dominant Alzheimer’s disease. Here, we report a Canadian-Vietnamese family carrying a PSEN1 p.Met233Val mutation with an exceptionally early and severe presentation that includes a wide range of atypical symptoms, including prominent ataxia, Parkinsonism, spasticity, dystonia, action tremor, myoclonus, bulbar symptoms, seizures, hallucinations and behavioral changes. Whole-exome sequencing (WES) was performed on the affected proband after many assessments over several years proved diagnostically inconclusive. The results were analyzed using the AnnEx “Annotated Exomes” browser (http://annex.can.ubc.ca), a web-based platform that facilitates WES variant annotation and interpretation. High-throughput sequencing can be especially informative for complex neurological disorders, and WES warrants consideration as a first-line clinical test. Data analyses facilitated by web-based bioinformatics tools have great potential for novel insight, although confirmatory, diagnostically accredited Sanger sequencing is recommended prior to reporting.
Citations
Citations to this article as recorded by
Presenilin Gene Mutation-associated Psychosis Mark A. Colijn, Zahinoor Ismail Alzheimer Disease & Associated Disorders.2024; 38(1): 101. CrossRef
A heterozygous de novo PSEN1 mutation in a patient with early-onset parkinsonism Yueting Chen, Peng Liu, Fei Xie, Bo Wang, Zhiru Lin, Wei Luo Neurological Sciences.2022; 43(2): 1405. CrossRef
Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force – An Update Lara M. Lange, Paulina Gonzalez‐Latapi, Rajasumi Rajalingam, Marina A.J. Tijssen, Darius Ebrahimi‐Fakhari, Carolin Gabbert, Christos Ganos, Rhia Ghosh, Kishore R. Kumar, Anthony E. Lang, Malco Rossi, Sterre van der Veen, Bart van de Warrenburg, Tom Warner Movement Disorders.2022; 37(5): 905. CrossRef
Progressive cognitive impairment and familial spastic paraparesis due to PRESENILIN 1 mutation: anatomoclinical characterization Miren Altuna, Rosa Larumbe, María Victoria Zelaya, Sira Moreno, Virginia García-Solaesa, Maite Mendioroz, María Antonia Ramos, María Elena Erro Journal of Neurology.2022; 269(9): 4853. CrossRef
Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene Jaya Bagaria, Eva Bagyinszky, Seong Soo A. An International Journal of Molecular Sciences.2022; 23(18): 10970. CrossRef
Scoring Algorithm‐Based Genomic Testing in Dystonia: A Prospective Validation Study Michael Zech, Robert Jech, Sylvia Boesch, Matej Škorvánek, Ján Necpál, Jana Švantnerová, Matias Wagner, Ariane Sadr‐Nabavi, Felix Distelmaier, Martin Krenn, Tereza Serranová, Irena Rektorová, Petra Havránková, Alexandra Mosejová, Iva Příhodová, Jana Šarlá Movement Disorders.2021; 36(8): 1959. CrossRef
PET/MRI Delivers Multimodal Brain Signature in Alzheimer’s Disease with De Novo PSEN1 Mutation Gayane Aghakhanyan, Dorothee Saur, Michael Rullmann, Christopher M. Weise, Matthias L. Schroeter, Ken Marek, Rami Abou Jamra, Solveig Tiepolt, Maria Strauss, Cordula Scherlach, Karl-Titus Hoffmann, Osama Sabri, Joseph Classen, Henryk Barthel Current Alzheimer Research.2021; 18(2): 178. CrossRef
Spinocerebellar Ataxia-Like Presentation of the M233V PSEN1 Mutation Yury Seliverstov, Ilya Kanivets, Sergey Illarioshkin The Cerebellum.2020; 19(5): 744. CrossRef
NetCore: a network propagation approach using node coreness Gal Barel, Ralf Herwig Nucleic Acids Research.2020; 48(17): e98. CrossRef
Diagnostic Approach of Early-Onset Dementia with Negative Family History: Implications from Two Cases of Early-Onset Alzheimer’s Disease with De Novo PSEN1 Mutation Jia Liu, Qianqian Wang, Donglai Jing, Ran Gao, Jing Zhang, Chunlei Cui, Hongwen Qiao, Zhigang Liang, Chaodong Wang, Pedro Rosa-Neto, Liyong Wu, Jianping Jia, Serge Gauthier Journal of Alzheimer's Disease.2019; 68(2): 551. CrossRef
A Clinical Case of Patient Carrying Rare Pathological PSEN1 Gene Mutation (L424V) Demonstrates the Phenotypic Heterogenity of Early Onset Familial AD Kaloyan R. Stoychev, Maya Stoimenova-Popova, Petranka Chumpalova, Lilia Ilieva, Mohamed Swamad, Zornitsa Kamburova-Martinova Frontiers in Psychiatry.2019;[Epub] CrossRef
Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy Ana I. Rojo, Marta Pajares, Angel J. García-Yagüe, Izaskun Buendia, Fred Van Leuven, Masayuki Yamamoto, Manuela G. López, Antonio Cuadrado Redox Biology.2018; 18: 173. CrossRef